Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEOutcome of Board MeetingResults29 Jul 2026

Laxmi Organic Industries Limited

Outcome of Board Meeting

Laxmi Organic Industries Limited has submitted its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, to the Board of Directors, which were reviewed by the Statutory Auditors.

Read more →📎 1 attachment
NSEStatement of deviation(s) or variation(s) under Reg. 32Results29 Jul 2026

Acme Solar Holdings Limited

Statement of deviation(s) or variation(s) under Reg. 32

Acme Solar Holdings Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32, stating that there has been no deviation or variation in the utilization of the proceeds raised through the Qualified Institutions Placement from the objects stated in the Placement Document.

Read more →📎 1 attachment
BSECompany UpdateResults29 Jul 2026

ACME Solar Holdings Ltd

Statement of Deviation or Variation in utilization of Proceeds of Qualified Institutions Placement for the quarter ended June 30, 2026

ACME Solar Holdings Ltd has filed a statement of deviation or variation in the utilization of proceeds from its Qualified Institutions Placement (QIP) for the quarter ended June 30, 2026, stating that there has been no deviation or variation in the utilization of the funds raised.

Read more →📎 1 attachment
NSECopy of Newspaper PublicationResults29 Jul 2026

Happiest Minds Technologies Limited

Copy of Newspaper Publication

Happiest Minds Technologies Limited has informed the Exchange about the publication of financial results for the quarter ended June 30, 2026, pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has shared the results through advertisements in Financial Express and Vishwavani newspapers.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults29 Jul 2026

Piramal Pharma Limited

Investor Presentation

Piramal Pharma Limited has announced its Q1 FY27 results, with a 17% revenue growth, 72% EBITDA growth, and 12.5% EBITDA margin expansion. The company's CDMO business delivered broad-based growth, while its Complex Hospital Generics and Consumer Healthcare businesses maintained leadership positions in their respective markets.

Read more →📎 1 attachment
NSEShareholders meetingResults29 Jul 2026

ETERNAL LIMITED

Shareholders meeting

Eternal Limited has filed a notice of its 16th annual general meeting to be held on August 26, 2026, and has uploaded its annual report for the financial year 2025-26 on its website.

Read more →📎 1 attachment
BSEResultResults29 Jul 2026

Piramal Pharma Ltd

Please find enlcosed UFR Q1 FY 27.

Piramal Pharma Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 1,124.95 crores, a decrease from Rs. 1,489.06 crores in the previous quarter. Net profit after tax was Rs. 113.48 crores, with basic EPS at Rs. 0.85.

Read more →📎 1 attachment
NSEMonitoring Agency ReportResults29 Jul 2026

Orient Green Power Company Limited

Monitoring Agency Report

Orient Green Power Company Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as per Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report is related to the utilization of proceeds from the Rights Issue of Rs. 250 crores raised in August 2024. The Monitoring Agency, Crisil Ratings Limited, has confirmed that there is no deviation from the objects of the issue.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults29 Jul 2026

EFC (I) Ltd

Press Release is attached.

EFC (I) Limited, a real estate-as-a-service platform, has announced its Q1 FY27 financial results, showing a 29% YoY growth in revenue to ₹2,829 Mn, with EBITDA at ₹1,230 Mn (up 20% YoY) and PAT at ₹708.5 Mn (up 52% YoY).

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults29 Jul 2026

Piramal Pharma Limited

Press Release

Piramal Pharma Limited announced its standalone and consolidated results for Q1 FY27, with a 17% revenue growth, 72% EBITDA increase, and 12.5% EBITDA margin expansion.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults29 Jul 2026

Quess Corp Ltd

Investor Presentation

Quess Corp Ltd has announced its Q1 FY27 results, with revenue at ₹ 4,182 Cr, growth of 15% YoY and 7% QoQ, and EBITDA at ₹ 85 Cr, growth of 21% YoY with margin of 2.02%. The company has also declared a final dividend of Rs. 3/- per share with record date of 7th August 2026.

Read more →📎 1 attachment
BSEAGM/EGM▲ PositiveResults29 Jul 2026

Alkem Laboratories Ltd

Please find attached herewith the Notice of AGM alongwith the Annual Report for the FY 2025-2026.

Alkem Laboratories Ltd has announced the Notice of 52nd Annual General Meeting (AGM) and Annual Report for FY 2025-2026. The AGM will be held on August 27, 2026, through Video Conferencing (VC)/ Other Audio-Visual Means (OAVM). The Annual Report highlights the company's growth journey, innovation, and diversification into new healthcare opportunities.

Read more →📎 1 attachment
BSEResultResults29 Jul 2026

Trident Lifeline Ltd

The Board of Directors inter-alia has approved and taken on record Un-Audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026

Trident Lifeline Ltd has announced its un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. The company's revenue from operations was ₹2,684.23 crore, with a net profit of ₹655.76 crore. The results were approved by the Board of Directors at their meeting held on July 29, 2026.

Read more →📎 1 attachment
← PreviousPage 1849 of 2375Next →